Beilstein J. Org. Chem.2008,4, No. 39, doi:10.3762/bjoc.4.39
Vladimir V. Ryakhovsky Georgy A. Khachiyan Nina F. Kosovova Elena F. Isamiddinova Andrey S. Ivanov R&D Dept., Pharm-Sintez, 38 Shosse Entusiastov, 111123 Moscow, Russia 10.3762/bjoc.4.39 Abstract MelanotanII is a synthetic cyclic heptapeptide used to prevent a sunlight-induced skin cancer by
γ-carboxy group of aspartic acid, led to a cyclic intermediate. Appending N-acetylnorleucine concluded the assembly of melanotanII molecule. Protection of the lateral groups in arginine and tryptophan was omitted for atom and step economy reasons. The total synthesis of melanotanII was
accomplished in 12 steps with 2.6% overall yield, affording >90% pure peptide without using preparative chromatography.
Keywords: melanotanII; solution phase synthesis; peptide synthesis; Introduction
Development of solid phase peptide synthesis methodology [1], recombinant techniques for expressing